Author: Binet, Quentin; Goffinet, Céline; Etogo-Asse, Frédérique-Estelle; Shaza, Leila
Title: Nonbacterial thrombotic endocarditis in a patient with gastric cancer and SARS-CoV-2 infection Cord-id: yxjw9dxh Document date: 2021_4_9
ID: yxjw9dxh
Snippet: Nonbacterial thrombotic endocarditis, formerly known as marantic endocarditis, is a very rare complication of advanced malignancy and other hypercoagulable states in which sterile, fibrin vegetations develop on heart valve leaflets. The most common malignancies associated with this entity are lung, pancreatic and gastric cancer. It has also been described as a presentation of COVID-19, which is known to be frequently complicated with coagulopathy and thromboembolic events. We report the case of
Document: Nonbacterial thrombotic endocarditis, formerly known as marantic endocarditis, is a very rare complication of advanced malignancy and other hypercoagulable states in which sterile, fibrin vegetations develop on heart valve leaflets. The most common malignancies associated with this entity are lung, pancreatic and gastric cancer. It has also been described as a presentation of COVID-19, which is known to be frequently complicated with coagulopathy and thromboembolic events. We report the case of a 62 year-old female patient newly diagnosed with stage IV gastric cancer and acute SARS-CoV-2 infection, presenting with confusion and homonymous hemianopsia in the setting of multiple acute ischemic strokes complicating a nonbacterial thrombotic mitral endocarditis. Herein, we discuss the underlying pathophysiology and make the hypothesis that SARS-CoV-2 infection could have participated in the pathogenesis of nonbacterial thrombotic endocarditis in our patient suffering from a gastric cancer.
Search related documents:
Co phrase search for related documents- abdominal pain and additional risk: 1, 2, 3, 4
- abdominal pain and lmwh low molecular weight heparin: 1
- abdominal pain and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- abdominal pain and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- active cancer and acute sars infection: 1, 2, 3, 4, 5, 6
- active cancer and additional risk: 1, 2, 3, 4, 5, 6, 7, 8
- acute inflammatory condition and low molecular weight: 1
- acute inflammatory condition and low molecular weight heparin: 1
- acute sars infection and additional risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute sars infection and additional risk confer: 1, 2
- acute sars infection and adhesion molecule: 1, 2, 3, 4, 5, 6
- acute sars infection and lmwh intermediate dose: 1
- acute sars infection and lmwh low molecular weight heparin: 1, 2, 3, 4
- acute sars infection and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute sars infection and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- additional risk and lmwh low molecular weight heparin: 1, 2, 3
- additional risk and low molecular weight: 1, 2, 3, 4, 5, 6
- additional risk and low molecular weight heparin: 1, 2, 3, 4, 5
- lmwh intermediate dose and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date